Alexandre Segelle

Alexandre Segelle

Auto-generated profile, based on publicly available information

Alexandre Segelle

Institute of Human Genetics, University of Montpellier, Centre National de la Recherche Scientifique, Montpellier, France

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2022 in Cell Reports
Verified
Journal Article
Open access
ASAlexandre Segelle
Alexandre Segelle
YNYaiza Núñez-Álvarez
Yaiza Núñez-Álvarez
AOAndrew J. Oldfield
Andrew J. Oldfield
KWKimberly M. Webb
Kimberly M. Webb
PVPhilipp Voigt
Philipp Voigt
RLReini Luco
Reini Luco
Histone modifications impact final splicing decisions. However, there is little evidence of the driving role of these marks in inducing cell-specific splicing changes. Using CRISPR epigenome editing tools, we show in an epithelial-to-mesenchymal cell reprogramming system (epithelial-to-mesenchymal transition [EMT]) that a single change in H3K27ac or H3K27me3 levels right at the alternatively spliced exon is necessary and sufficient to induce a splicing change capable of recapitulating important aspects of EMT, such as cell motility and invasiveness. This histone-mark-dependent splicing effect is highly dynamic and mediated by direct recruitment of the splicing regulator PTB to its RNA binding sites. These results support a role for H3K27 marks in inducing a change in the cell's phenotype via regulation of alternative splicing. We propose the dynamic nature of chromatin as a rapid and reversible mechanism to coordinate the splicing response to cell-extrinsic cues, such as induction of EMT.